Search

One role of the ICCon partnership is to establish a national database of individuals found to have gene faults or mutations causing an increased risk of cancer. Databases such as this enable researchers to investigate the causes... Read more

This is an international prostate cancer screening study for men with inherited BRCA and mismatch repair (MMR) gene mutations who are at increased risk of prostate cancer. Peter Mac coordinates the Australian axis of the study.... Read more

Genetics and genomics are dramatically changing the landscape of how we understand cancer risk, as well as diagnose and treat cancer. The Psychosocial Cancer Genetics Research aims to understand how genetics and genomics impact... Read more

The ViP (Variants in Practice) study is a clinic-based cohort of high-risk breast and ovarian cancer families.Our goal is to offer participation in ongoing genomic research to all families undergoing assessment and genetic... Read more

PRiMo is a trial of the use of polygenic risk scores in clinical practice designed to identify the optimal method of assessing potentially high-risk women and personalising breast cancer risk management.Hypothesis: Personalised... Read more

Employing two Positron Emission Tomography (PET), computed tomography (CT) scanners, our team non-invasively images tumour biology. This includes processes such as metabolism, proliferation, amino acid transport, and hypoxia to... Read more